All Helmholtz Munich articles

  • pexels-lalu-_ua-6928295-7120271
    News

    Ancient viral DNA shapes early embryo development

    2025-01-21T08:53:00Z

    Over half of our genomes consists of remnants of ancient viral DNA which are widespread across the tree of life. Once dismissed as the ’dark side’ of the genome, researchers have now revealed the role of transposable elements in early embryo development.

  • Low-Res_PM EBViously
    News

    Start-up EBViously announces its launch

    2024-12-18T10:48:00Z

    EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).

  • 10266_lores
    News

    Innovative antiviral defense with new CRISPR tool

    2024-04-15T09:30:00Z

    Scientists outline how they have overcome a significant obstacle that has hampered the effectiveness of Cas13d: its restriction to the nucleus of mammalian cells. 

  • Immunohistochemical_detection_of_Helicobacter_pylori_histopathology
    News

    Achilles heel is uncovered in Helicobacter pylori

    2023-04-27T08:56:00Z

    Researchers have discovered a weakness in the bacterium Helicobacter pylori, which could be exploited to develop new drugs.